NCT02339818View on ClinicalTrials.gov

Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Stroke, Systemic Embolism, VTEt and VTEp
Trial Locations (1)

08540

Local Institution, Princeton

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY